Caille Vincent, Chiche Jean-Daniel, Nciri Noureddine, Berton Christine, Gibot Sébastien, Boval Bernadette, Payen Didier, Mira Jean-Paul, Mebazaa Alexandre
Department of Anesthesiology and Critical Care Medicine and Laboratory of Hematology, Lariboisière University Hospital, IFR 06, University Paris 7, Paris, France.
Shock. 2004 Dec;22(6):521-6. doi: 10.1097/01.shk.0000143410.63698.57.
Although the expression of monocyte histocompatibility leukocyte antigen (HLA)-DR has been shown to be decreased during human sepsis, its level of expression in other nonseptic critical conditions is unclear. The aim of this study was to compare the level of HLA-DR expression on circulating monocytes among patients with septic, hemorrhagic, and cardiogenic shocks and severe sepsis without shock. At admission, HLA-DR expression was exclusively decreased in patients with septic shock (n = 30; P < 0.001), whereas the expression was similar between the other studied groups: cardiogenic shock (n = 16), hemorrhagic shock (n = 11), severe sepsis without shock (n = 18), and healthy volunteers (n = 8). HLA-DR expression was not predictive for overall mortality, but at day 1, an HLA-DR expression of less than 14 of mean fluorescence intensity (that corresponds to 40% labeled monocytes) was predictive of mortality exclusively in patients with septic shock (odds ratio, 11.4 and 95% confidence interval, 1.7; 78.4; P < 0.008). Catecholamine infusion, mechanical ventilation, positive blood culture, and number of units of blood or plasma transfused did not correlate with decreased HLA-DR expression. Thus, the decrease in HLA-DR expression is specific to septic shock and is associated, in septic shock patients, with increased mortality risk.
虽然单核细胞组织相容性白细胞抗原(HLA)-DR的表达在人类脓毒症期间已被证明会降低,但其在其他非脓毒症危急情况下的表达水平尚不清楚。本研究的目的是比较脓毒症性休克、失血性休克、心源性休克患者以及无休克的严重脓毒症患者循环单核细胞上HLA-DR的表达水平。入院时,HLA-DR表达仅在脓毒症性休克患者中降低(n = 30;P < 0.001),而在其他研究组中表达相似:心源性休克(n = 16)、失血性休克(n = 11)、无休克的严重脓毒症(n = 18)和健康志愿者(n = 8)。HLA-DR表达不能预测总体死亡率,但在第1天,平均荧光强度低于14(对应40%标记单核细胞)的HLA-DR表达仅在脓毒症性休克患者中可预测死亡率(优势比为11.4,95%置信区间为1.7;78.4;P < 0.008)。儿茶酚胺输注、机械通气、血培养阳性以及输注的血液或血浆单位数与HLA-DR表达降低无关。因此,HLA-DR表达降低是脓毒症性休克所特有的,并且在脓毒症性休克患者中与死亡风险增加相关。